Pharmaceutical Compliance Consulting in Egypt
PHARPRO supports Egypt's pharmaceutical manufacturers with CSV validation, QA gap assessments, CQV, thermal mapping and GMP training, structured around Egyptian Drug Authority (EDA) requirements and available on-site or remotely.
Understanding the Egypt Pharmaceutical Landscape
Egypt has the largest pharmaceutical manufacturing sector in Africa and one of the most dynamic in the MENA region, with over 130 licensed manufacturers. The Egyptian Drug Authority (EDA) is actively modernising its inspection and licensing framework, increasingly aligning with WHO GMP and EU GMP standards. Export-oriented Egyptian manufacturers face additional regulatory scrutiny from international authorities.
PHARPRO has worked with pharmaceutical clients across Egypt - both remotely and on-site - delivering CSV validation, QA support, and GMP training that meets the regulatory expectations your team faces.
Compliance Services for Egypt Pharma
Remote and on-site support, delivered at the pace your programme requires.
CSV Validation
Full-lifecycle CSV for pharma software and laboratory systems. IQ/OQ/PQ, URS, risk classification, and audit trail review - aligned with EU GMP Annex 11 and FDA 21 CFR Part 11.
QA & Gap Assessment
Gap assessments against Egyptian Drug Authority (EDA) and international GMP standards. SOP reviews, CAPA management, and data integrity programmes.
CQV & Thermal Mapping
Equipment and utility qualification (IQ/OQ/PQ) and temperature mapping studies for Egypt pharmaceutical warehouses, cold chain facilities, and manufacturing areas.
GMP Training
Customised GMP training for Egypt pharma teams - data integrity, CSV fundamentals, IQ/OQ/PQ methodology, and inspection readiness.
Inspection Readiness
Mock audits and gap assessments to prepare your Egypt site for Egyptian Drug Authority (EDA) inspections and international authority audits.
CAPA Management
Root cause analysis, corrective and preventive action planning, and CAPA effectiveness checks - aligned with ICH Q10 and GMP requirements.
Regulations We Work Within in Egypt
All PHARPRO work in Egypt is aligned with applicable local and international regulatory standards.
Frequently Asked Questions - Egypt
Yes. PHARPRO works with pharmaceutical manufacturers, distributors and contract organisations throughout Egypt, covering CSV validation, QA gap assessments, GMP training and inspection readiness, delivered remotely or on-site as the project requires.
Pharmaceutical companies in Egypt must comply with Egyptian Drug Authority (EDA) requirements, aligned with EDA GMP Requirements, WHO GMP Guidelines (TRS 986, Annex 2), and EU GMP for export-focused manufacturers.
Yes. Egypt clients typically combine remote CSV documentation, QA assessment and training work with occasional on-site visits — Mohammad travels for thermal mapping, facility walkthroughs and mock inspections when the project calls for it.
Urgent Egypt engagements, such as a pending inspection or regulatory finding, can start remotely within 3-5 business days. For planned work, the typical kickoff is 1-2 weeks after the proposal is agreed.
Ready to start your Egypt compliance project?
Start with a free 30-minute compliance assessment. No commitment, no sales pitch.
Services in Egypt